Fresenius Kabi Honored with Premier’s 2025 Supplier Legacy Award
Fresenius Kabi, a leading provider of essential medicines and medical technologies and a key part of the global healthcare company, has been recognized with the prestigious 2025 Supplier Legacy Award from Premier, Inc. Premier is a top technology-driven healthcare performance improvement company that connects members across the U.S. healthcare system to drive better outcomes.
This award marks the fifth time since 2015 that Kabi USA has earned this distinguished recognition for operational excellence, reflecting its long-term commitment to Premier members and its sustained delivery of value in the healthcare supply chain.
Recognizing Excellence in Service and Value Creation
The Supplier Legacy Award honors suppliers who have demonstrated exceptional performance and have maintained a tenure of over three years as contracted Premier partners. It was specifically acknowledged for:
- Providing exceptional local customer service and engagement
- Creating value through clinical excellence
- Maintaining a steadfast commitment to cost reduction without compromising quality
This ongoing dedication has enabled Premier members—who collectively represent more than 4,350 U.S. hospitals and health systems—to enhance care delivery while controlling expenses.
“This award recognizes the commitment to service, innovation and collaboration by thousands of employees from across our company,” said Arun Verma, President of Fresenius Kabi Region U.S. and Member of the Executive Leadership Team at Fresenius Kabi AG. “It’s especially gratifying to receive this award from a customer whose members make up more than 4,350 U.S. hospitals and health systems.”
Partnership Driving Clinical and Operational Improvements
Premier’s Senior Vice President of Supply Chain, Bruce Radcliff, praised it’s role in supporting the healthcare community. “It supports Premier members by offering products and services that help improve costs, quality and operations—and deliver overall value,” he said. “We’re honored to recognize it as a Supplier Legacy Award recipient.”
The award highlights the company’s ability to work collaboratively with healthcare providers to solve complex challenges, improve patient outcomes, and reduce operational inefficiencies.
Celebrating at Premier’s Annual Breakthroughs Conference
It was officially honored during Premier’s annual Breakthroughs Conference & Exhibition, held from July 15 to 17, 2025. This event brings together healthcare leaders and innovators to share best practices and celebrate achievements that drive industry progress.
The recognition at the conference is an important milestone that underscores it’s ongoing leadership in the healthcare supply chain and its consistent delivery of quality products and services.
A History of Recognition and Innovation
This 2025 award marks the fifth time Premier has bestowed the Supplier Legacy Award on it, with previous wins in 2015, 2017, 2018, and 2021. The company’s strong track record reflects its sustained operational excellence and ongoing partnership with Premier.
In addition to the Supplier Legacy Award, It received Premier’s Trailblazer Award in 2024. This honor is one of Premier’s highest and recognizes suppliers who deliver innovative, scalable methods and technologies that accelerate the translation of clinical evidence into real-world practice—helping providers improve patient care at scale.
Looking Ahead: Continued Commitment to Healthcare Excellence
Receiving the Supplier Legacy Award once again cements it’s role as a trusted partner in the healthcare industry, committed to advancing both clinical outcomes and operational efficiency. The company plans to continue leveraging its expertise and innovation to support Premier members and the broader healthcare community.
As healthcare systems face growing pressures to improve quality while controlling costs, partnerships like that of Fresenius Kabi and Premier play a critical role in driving sustainable, meaningful progress.
About Fresenius Kabi
As a global health care company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status – notably as the only corporation offering both product groups. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more.
Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. In line with the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of health care.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing health care solutions on a global scale.
For more information, please visit www.fresenius-kabi.com. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn and Facebook.
